PCP CORE DIRECTIVES Flashcards
supraglottic airway indications
- need for ventilatory assistance or airway control,
and - other airway management is ineffective
supraglottic airway conditions
absent gag reflex
supraglottic airway contraindications
- airway obstructed by a foreign object,
- known esophageal disease (varices)
- trauma to the oropharynx
- caustic ingestion
supraglottic airway treatment (insertion)
the max number of attempts is 2
supraglottic airway treatment (confirmation of placement)
primary: etco2 waveform capnography
secondary: etco2 non waveform, auscultation, chest rise
SGA clinical considerations
- An attempt at supraglottic airway insertion is defined as the insertion of the supraglottic airway into the mouth.
- Confirmation of supraglottic airway should use ETCO2 (Waveform capnography). If waveform capnography is not available or is not working, then at least 2 secondary methods must be used.
bronchoconstriction indications
- respiratory distress and
- suspected bronchoconstriction
bronchoconstriction conditions salbutamol
n/a
bronchoconstriction conditions EPI
rr- bvm ventilation required
other- hx of asthma
bronchoconstriction conditions dexamethasone
other: hx of asthma OR, COPD OR, 20 pack-year hx of asthma
bronchoconstriction contraindications salbutamol
allergy/sensitivity to salbutamol
bronchoconstriction contraindications EPI
allergy/ sensitivity to epi
bronchoconstriction contraindications dexamethasone
- allergy or sensitivity to steroids
- currently on PO or parenteral steroids
bronchoconstriction treatment salbutamol (weight <25kg)
- MDI
600 mcg
5-15mins
3 times - NEB
2.5mg
5-15 mins
3 times
bronchoconstriction treatment salbutamol (weight >25kg)
- MDI
800 mcg
5-15mins
3 times - NEB
5 mg
5-15 mins
3 times
bronchoconstriction epinephrine treatment
- IM
1mg/ml
0.01mg/kg
max 0.5mg
1 time
bronchoconstriction dexamethasone treatment
-PO/IM/IV
0.5mg/kg
max 8mg
1 time
bronchoconstriction clinical considerations
- epi should be the 1st medication administered if the patient is apneic. salbutamol may be administered subsequently using BVM MDI adapter
- neb is contraindicated for pt with known or suspected fever or in setting of declared illness outbreak
- MDI salbutamol administered every 4 breaths
- spacer should be used when administering salbutamol MDI
moderate to severe allergic reaction indications
exposure to probable allergen and signs and symptoms of a mod- severe allergic reaction incl anaphylaxis
moderate to severe allergic reaction conditions epinephrine
- for anaphylaxis only
moderate to severe allergic reaction conditions diphenhydramine
- > 25kg
moderate to severe allergic reaction contraindications epinephrine
allergy or sensitivity to epinephrine
moderate to severe allergic reaction contraindications diphenhydramine
allergy or sensitivity to diphenhydramine
moderate to severe allergic reaction treatment epinephrine
- IM
1mg/ml
0.01mg/kg
max 0.5mg
minimum 5 mins
2 times